The Next Evolution of TLIF: Where Innovation Meets Clinical Evidence

Leave a Comment / By /

New evidence, FDA approval, and Medicare NTAP status expand Infuse™ bone graft use in TLIF.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top